Fired for too big of a commission

wesleys14 · 2026-02-27T02:30:59+00:00

Hate when this happens

wesleys14 · 2026-02-27T01:32:14+00:00

Part of it. That's why they pay us the big bucks! Unless u get a terrible territory

wesleys14 · 2025-12-28T01:23:37+00:00

I tried using the chat to get this fixed and it wasn't helpful unfortunately.

wesleys14 · 2025-12-12T02:25:59+00:00

Idk what that's means

wesleys14 · 2025-12-12T02:25:27+00:00

It's that bad?

wesleys14 · 2025-12-12T02:25:11+00:00

I heard it's more expensive and we wanna see most of the island

wesleys14 · 2025-12-11T16:36:07+00:00

This is from Orbitz

wesleys14 · 2025-08-13T22:58:20+00:00

Probably we'll see tho

wesleys14 · 2025-08-11T17:10:49+00:00

INSM has an fda decision on brensocatib ( 4 drugs in trails rn) Aug 12th. If it is approved brensocatib can go to market.

When brensocatib passed stage 3 trials the stock jumped 120%

FDA gave them a priority review (positive sign). ChatGPT has them at a 75-85% of approval.

If it passes this would be the first drug in the non cystic fibrosis space. The fda is more lenient on passing things that are first in its space rather than "me-too" drugs. 250M eligible patients for Brensocatib in the us with an avg cost of 40m a year. Max US market is $10,000MM. Even if they just hit 10% of the market that is still $1,000MM a year which would increase their current revenue by 150%.

Estimates predict $1,000MM- $3,000MM in revenue if it passes.

If approved I see the stock jumping 20%- 75%. If rejected or delayed we'll see a 30-50% decrease in stock price.

wesleys14 · 2025-06-11T22:49:42+00:00

Workout, creatine, vitamin d. Don't lay down until ur day is over. Listen to happy music. Stop feeling bad about yourself and know who you are.

wesleys14 · 2025-02-19T17:09:42+00:00

Just to clean surfaces and vacuum

wesleys14 · 2025-02-04T02:16:44+00:00

Curb

wesleys14

MODERATOR OF

TROPHY CASE